Verified peer comparison
Halozyme Therapeutics vs AnaptysBio Financial Comparison
Direct answer
Halozyme Therapeutics and AnaptysBio are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Halozyme Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Halozyme Therapeutics Revenue
- 1,396,611,000 USD
- AnaptysBio Revenue
- 234,603,000 USD
- Halozyme Therapeutics Operating income
- 816,293,000 USD
- AnaptysBio Operating income
- 47,896,000 USD